- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Digirad unveils solid-state detector
Digirad is a San Diego-based company that is developing a mobilegamma camera that uses solid-state digital detectors rather thanscintillation crystals and photomultiplier tubes to detect scintillationevents. The technology could represent the next step
Digirad is a San Diego-based company that is developing a mobilegamma camera that uses solid-state digital detectors rather thanscintillation crystals and photomultiplier tubes to detect scintillationevents. The technology could represent the next step in nuclearmedicine detector technology by offering improved image resolution(SCAN 7/6/95).
Digirad will display a detector head from its DigiCam NotebookImager, a gamma camera under development. When completed, thecamera will be mounted on a wheeled cart about the size of anultrasound scanner and will employ a small cadmium zinc telluridedetector for organ-specific imaging. The detector head measuresabout 8 x 8 inches and weighs 25 pounds with collimator. Digiradhopes to file a 510(k) application for DigiCam Notebook Imagerin 1996.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
